|
|
| Line 4: |
Line 4: |
|
| |
|
| ==Overview== | | ==Overview== |
|
| |
| '''Hemolytic anemia''' is [[anemia]] due to [[hemolysis]], the abnormal breakdown of [[red blood cell]]s either in the [[blood vessel]]s (intravascular hemolysis) or elsewhere in the body (extravascular). In a healthy person, a red blood cell survives 90 to 120 days (on average) in the circulation, so about 1% of human red blood cells break down each day. The [[spleen]] (part of the [[reticulo-endothelial system]]) is the main organ which removes old and damaged RBCs from the circulation. In health the break down and removal of RBCs from the circulation is matched by the production of new RBCs in the [[bone marrow]]. When the rate of breakdown increases, the body compensates by producing more RBCs, but if compensation is inadequate clinical problems can appear. Breakdown of RBCs can exceed the rate that the body can make RBCs and so anemia can develop.
| |
|
| |
|
| ==Historical Perspective== | | ==Historical Perspective== |
Revision as of 19:25, 23 October 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating [Disease] from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Natural History
Complications
Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
References
Template:WS
Template:WH